These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36201021)

  • 1. Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.
    Mikel CC; Goldfarb DS; Ponte A; Steigelman K; Latyshev S
    Urolithiasis; 2022 Dec; 50(6):721-727. PubMed ID: 36201021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cystine excretion and capacity in patients with cystinuria.
    Goldfarb DS; Coe FL; Asplin JR
    Kidney Int; 2006 Mar; 69(6):1041-7. PubMed ID: 16501494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
    Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS
    J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for the management of cystinuria: a systematic review.
    Bhatt NP; Deshpande AV; Starkey MR
    J Nephrol; 2024 Mar; 37(2):293-308. PubMed ID: 37957454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria.
    Fjellstedt E; Denneberg T; Jeppsson JO; Christensson A; Tiselius HG
    Urol Res; 2001 Oct; 29(5):303-10. PubMed ID: 11762791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria.
    Lindell A; Denneberg T; Jeppsson JO
    Nephron; 1995; 71(3):328-42. PubMed ID: 8569983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria.
    Malieckal DA; Modersitzki F; Mara K; Enders FT; Asplin JR; Goldfarb DS
    Urolithiasis; 2019 Dec; 47(6):549-555. PubMed ID: 30980122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystinuria].
    Prot-Bertoye C; Daudon M; Tostivint I; Dousseaux MP; Defazio J; Traxer O; Knebelmann B; Courbebaisse M
    Nephrol Ther; 2021 Apr; 17S():S100-S107. PubMed ID: 33910689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and cystine stone formation during tiopronin treatment.
    Lindell A; Denneberg T; Hellgren E; Jeppsson JO; Tiselius HG
    Urol Res; 1995; 23(2):111-7. PubMed ID: 7676533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.
    Cil O; Perwad F
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32245805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interaction of thiol drugs and urine pH in the treatment of cystinuria.
    Asplin DM; Asplin JR
    J Urol; 2013 Jun; 189(6):2147-51. PubMed ID: 23261477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of the medical management of cystinuria.
    Pietrow P; Auge BK; Weizer AZ; Delvecchio FC; Silverstein AD; Mathias B; Albala DM; Preminger GM
    J Urol; 2003 Jan; 169(1):68-70. PubMed ID: 12478105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystinuria in children and young adults: success of monitoring free-cystine urine levels.
    Dello Strologo L; Laurenzi C; Legato A; Pastore A
    Pediatr Nephrol; 2007 Nov; 22(11):1869-73. PubMed ID: 17694338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystine crystal volume determination: a useful tool in the management of cystinuric patients.
    Daudon M; Cohen-Solal F; Barbey F; Gagnadoux MF; Knebelmann B; Jungers P
    Urol Res; 2003 Jul; 31(3):207-11. PubMed ID: 12748836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections.
    Kumar A; Estes Bright LM; Garren MRS; Manuel J; Shome A; Handa H
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43332-43344. PubMed ID: 37671841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass Spectrometry-based
    Bose N; Zee T; Kapahi P; Stoller ML
    Bio Protoc; 2017 Jul; 7(14):. PubMed ID: 28868331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on cystine stones: current and future concepts in treatment.
    Moussa M; Papatsoris AG; Abou Chakra M; Moussa Y
    Intractable Rare Dis Res; 2020 May; 9(2):71-78. PubMed ID: 32494553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion.
    Hoppe A; Denneberg T; Jeppsson JO; Kågedal B
    Br Vet J; 1993; 149(3):235-51. PubMed ID: 8334506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria.
    Parvex P; Rozen R; Dziarmaga A; Goodyer P
    Mol Genet Metab; 2003 Dec; 80(4):419-25. PubMed ID: 14654355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.